Drug Trial Radar · NCT01747174
REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
Last checked: Nov 20, 2026Latest source record: Jun 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
247
Actual
Start
Oct 2011
Primary completion
Oct 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- University Hospitals, LeicesterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 11, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether intra-coronary adenosine or sodium nitroprusside (SNP) delivered selectively via a thrombus aspiration catheter (or if unsuccessful via a coronary microcatheter) following thrombus aspiration in Primary Percutaneous Coronary Intervention (P-PCI) reduces microvascular obstruction (MVO) parameters and infarct size as measured with cardiac MRI, compared with standard treatment following thrombus aspiration in patients presenting with ST-elevation myocardial infarction (STEMI).
Conditions
- ST-elevation Myocardial Infarction (STEMI)
Interventions
IC AdenosineDrug
IC Adenosine 1mg injected distally via micro-catheter in to IRA following thrombus aspiration with further dose (1mg if IRA is RCA otherwise 2mg) via guide catheter following coronary stent deployment.
IC Sodium nitroprusside (SNP)Drug
IC SNP 250mcg injected distally via micro-catheter distally in to IRA following thrombus aspiration with further 250 mcg dose delivered via guide catheter following coronary stent deployment.
Standard PCIProcedure
PCI procedure with thrombectomy (via aspiration catheter) and bivalirudin given as standard.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CMR measured infarct size (% LV mass)Time frame: 48-72 hours post procedure
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Glenfield Hospital
Leicester, Leicestershire, United Kingdom
Freeman Hospital
Newcastle upon Tyne, Tyne and Wear, United Kingdom
University Hospital
Coventry, West Midlands, United Kingdom
Leeds General Infirmary
Leeds, West Yorkshire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.